Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AKTX

Akari Therapeutics Plc ADR

7.00

Aug 07 • 3:59 PM ET -1.08 (-13.37%)

7.62

Aftermarket • 7:59 PM ET +0.62 (8.79%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	7.98M
Enterprise Value	5.88M
Income	-28.00M
Sales	0.00M
Book/sh	12.56
Cash/sh	2.48
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.56
P/C	2.82
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.27
Current Ratio	0.27
Debt/Eq	0.05
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-18.86
EPS next Y	-2.56
EPS next Q	-1.04
EPS this Y	61.27%
EPS next Y	68.04%
EPS next 5Y	44.90%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-75.83%
Sales Q/Q	-
Earnings	May 14
EPS/Sales Surpr.	-632.33% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	14.02%
Inst Trans	34.85%
ROA	-66.00%
ROE	-155.01%
ROIC	-194.71%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-25.49%
SMA50	-40.17%
SMA200	-40.43%
Trades

Shs Outstand	1.14M
Shs Float	1.14M
Short Float	1.44%
Short Ratio	0.02
Short Interest	0.02M
52W High	49.60 -85.89%
52W Low	3.02 132.17%
Volatility	10.44% 12.46%
ATR (14)	1.27
RSI (14)	35.18
Beta	1.39
Rel Volume	0.09
Avg Volume	782.94K
Volume	68,965

Perf Week	-10.94%
Perf Month	-46.81%
Perf Quarter	6.38%
Perf Half Y	-22.22%
Perf YTD	-39.45%
Perf Year	-82.67%
Perf 3Y	-96.70%
Perf 5Y	-99.48%
Perf 10Y	-99.92%
Recom	1.00
Target Price	30.00
Prev Close	8.08
Price	7.00
Change %	-13.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)